Seelos Therapeutics to Present a Poster on SLS-002 at the 2021 IASR/AFSP International Summit on Suicide Research Psychedelics Investing
Awakn Life SciencesAcquires Exclusive Rights to MDMA Research from Imperial College London Psychedelics Investing
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD. Psychedelics Investing
COMPASS Pathways to participate in upcoming Maxim and Cantor investor conferences Psychedelics Investing
Awakn Life Sciences to Present at the Oppenheimer and Maxim Group September Investor Conferences Psychedelics Investing
Awakn Life Sciences to Acquire Leading Ketamine-Assisted Psychotherapy Clinic in Norway Psychedelics Investing
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board Psychedelics Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
